| 2018 | Pharmacological effects of carrier fluids on the hyperthermic intraperitoneal chemotherapy using oxaliplatin
| Dissertation |
| 2021 | Pharmacological Inhibition of Sonic Hedgehog Signaling Suppresses Tumor Development in a Murine Model of Intrahepatic Cholangiocarcinoma
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
| 2013 | Pharmacological prevention of rocuronium-induced injection pain or withdrawal movements: a meta-analysis | JOURNAL OF ANESTHESIA |
| 2018 | Pharmacological target therapy of neuropathic pain and patient-reported outcomes in patients with chronic low back pain in Korea: Results from the NLBP Outcomes Research.
| MEDICINE |
| 1996 | Pharmacology of the spinal adenosine receptor which mediates the antiallodynic action of intrathecal adenosine agonists | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS |
| 2006 | Pharmacotheraphy for alcohol dependence: Anticraving medications for relapse prevention
| YONSEI MEDICAL JOURNAL |
| 2019 | Pharyngeal obstruction due to hemorrhagic bullae in a patient with anti-BP180-type mucous membrane pemphigoid associated with acquired hemophilia A | JOURNAL OF DERMATOLOGY |
| 2020 | Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
| BRITISH JOURNAL OF CANCER |
| 2022 | Phase 1 trial of vibostolimab plus pembrolizumab for PD-1/PD-L1 inhibitor-naive advanced gastric cancer: The KEYVIBE-001 trial | ANNALS OF ONCOLOGY |
| 2021 | Phase 1b Open-Label Trial of Afatinib Plus Xentuzumab (BI 836845) in Patients With EGFR Mutation-Positive NSCLC After Progression on EGFR Tyrosine Kinase Inhibitors
| JTO Clinical and Research Reports |
| 2020 | Phase 2 study of afatinib among patients with recurrent and/or metastatic esophageal squamous cell carcinoma | CANCER |
| 2018 | Phase 2 Study of an Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma (KMM150) | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
| 2015 | Phase 2 study of dovitinib in patients with metastatic or unresectable adenoid cystic carcinoma | CANCER |
| 2017 | Phase 2 study of intermittent pulse dacomitinib in patients with advanced non-small cell lung cancers | LUNG CANCER |
| 2022 | Phase 2 study of pembrolizumab-based combination therapy in patients with microsatellite instability-high or mismatch repair-deficient stage IV colorectal cancer | ANNALS OF ONCOLOGY |
| 2021 | Phase 2 study of TAS-117, an allosteric akt inhibitor in advanced solid tumors harboring phosphatidylinositol 3-kinase/v-akt murine thymoma viral oncogene homolog gene mutations
| INVESTIGATIONAL NEW DRUGS |
| 2023 | Phase 2 trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancers
| HEPATOLOGY |
| 2023 | Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms
| FRONTIERS IN ONCOLOGY |
| 2020 | Phase 4 Study in Patients From Asia With Gastroesophageal Reflux Disease Treated With Dexlansoprazole
| JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY |
| 2012 | Phase detection using doppler effect based optical heterodyne interferometry
| Thesis |
